Serotonin

Serotonin (), alternatively designated as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with diverse physiological roles in both the central nervous system (CNS) and peripheral tissues. Its functions encompass mood regulation, cognition, reward processing, learning, memory, and physiological processes, including emesis and vasoconstriction. Within the central nervous system, serotonin modulates affect, ingestive behavior, and somnolence.

Serotonin (), also known as 5-hydroxytryptamine (5-HT), is a monoamine neurotransmitter with a wide range of functions in both the central nervous system (CNS) and also peripheral tissues. It is involved in mood, cognition, reward, learning, memory, and physiological processes such as vomiting and vasoconstriction. In the CNS, serotonin regulates mood, appetite, and sleep.

Approximately 90% of the body's serotonin is synthesized in the gastrointestinal tract by enterochromaffin cells, where it governs gastrointestinal motility. Lesser quantities are generated in the raphe nuclei of the brainstem, the Merkel cells of the skin, pulmonary neuroendocrine cells, and taste receptor cells of the tongue. Following secretion, serotonin is absorbed by blood platelets, which subsequently release it during coagulation to facilitate vasoconstriction and platelet aggregation. Approximately 8% of the total bodily serotonin is sequestered within platelets, while 1–2% resides in the CNS.

Serotonin functions as both a vasoconstrictor and a vasodilator, contingent upon its local concentration and physiological context, thereby impacting hemostasis and the regulation of blood pressure. It contributes to the stimulation of myenteric neurons and the enhancement of gastrointestinal motility, mediated by uptake and release cycles involving platelets and adjacent tissues. From a biochemical perspective, serotonin is an indoleamine derived from tryptophan, undergoing primary metabolism in the liver to yield 5-hydroxyindoleacetic acid (5-HIAA).

Serotonin constitutes a therapeutic target for various classes of antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs), which inhibit its synaptic reuptake, thereby increasing its extracellular concentrations. This compound is present in nearly all bilateral animals, encompassing insects, spiders, and worms, and is additionally observed in fungi and plants. Within plants and insect venom, it fulfills a defensive role by eliciting nociception. Serotonin liberated by pathogenic amoebae can induce diarrhea in the human gastrointestinal tract, whereas its occurrence in seeds and fruits is hypothesized to stimulate digestion and promote seed dispersal.

Molecular structure

Biochemically, the indoleamine molecule is synthesized from the amino acid tryptophan through a two-step process: initially, a rate-limiting hydroxylation occurs at the 5-position of the indole ring, forming the intermediate 5-hydroxytryptophan, followed by decarboxylation to yield serotonin. Its preferred conformations are determined by the ethylamine side chain, leading to the existence of six distinct conformers.

Crystal structure

Serotonin crystallizes within the P2₁2§23₄5§ chiral space group, establishing diverse hydrogen-bonding interactions among serotonin molecules through N-H...O and O-H...N intermolecular bonds. Furthermore, serotonin forms various salts, such as the pharmaceutical formulation of serotonin adipate.

Biological role

Serotonin participates in a multitude of physiological processes, encompassing sleep, thermoregulation, learning and memory, nociception, social behavior, sexual activity, feeding, motor activity, neural development, and biological rhythms. In simpler organisms, such as certain invertebrates, serotonin modulates ingestive behavior and other biological functions. Within plants, serotonin biosynthesis appears to correlate with stress responses. Notwithstanding its historical emphasis in pharmaceutical marketing, the assertion that diminished serotonin levels are causative of depression lacks substantiation from scientific evidence.

Cellular effects

Serotonin exerts its primary actions via its cognate receptors, with its physiological effects being contingent upon the specific cellular and tissue expression profiles of these receptors.

Its metabolism commences with oxidation by monoamine oxidase, yielding 5-hydroxyindoleacetaldehyde (5-HIAL). The rate-determining step in this process involves the transfer of a hydride from serotonin to the flavin cofactor. Subsequent oxidation by aldehyde dehydrogenase (ALDH) converts this intermediate into 5-hydroxyindoleacetic acid (5-HIAA), an indole acetic-acid derivative. This final metabolite is subsequently eliminated renally.

Receptors

Serotonin receptors, situated on the cell membranes of neuronal and other animal cell types, mediate the actions of serotonin as an endogenous ligand, alongside a diverse array of pharmaceutical and psychedelic compounds. Currently, 14distinct serotonin receptors have been identified, encompassing the serotonin 5-HT§23§ (_1A, _1B, _1D, _1E, _1F), 5-HT§14_{15§ (2A, 2B, 2C), 5-HT§22}23§, 5-HT§24_{25§, 5-HT§26}27§ (_5A, _5B), 5-HT§32_{33§, and 5-HT§34}35§ receptors. With the exception of the serotonin 5-HT§3637§ receptor, which functions as a ligand-gated ion channel, all other 5-HT receptors are G-protein-coupled receptors (also known as seven-transmembrane or heptahelical receptors) that initiate an intracellular second messenger cascade. Notably, the 5-HT_5B receptor is found in rodents but is absent in humans.

Beyond its interaction with serotonin receptors, serotonin also functions as an agonist for trace amine-associated receptor 1 (TAAR1) in certain species. Specifically, it acts as a weak partial agonist for TAAR1 in rats, yet exhibits no activity at TAAR1 in mice and humans.

The cryo-electron microscopy (cryo-EM) structures of the serotonin 5-HT_2A receptor, both in complex with serotonin and with various serotonergic psychedelics, have been elucidated and documented by Bryan L. Roth and his research team.

Termination

Serotonergic activity is primarily terminated by the reuptake of 5-HT from the synaptic cleft. This process is mediated by the specific monoamine transporter for 5-HT, known as SERT, located on the presynaptic neuron. Several pharmacological agents, including cocaine, dextromethorphan (an antitussive), tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs), are capable of inhibiting 5-HT reuptake. A study conducted in 2006 revealed that a substantial proportion of 5-HT's synaptic clearance results from the selective action of the plasma membrane monoamine transporter (PMAT), which actively transports the molecule across the membrane and back into the presynaptic cell.

Unlike SERT, which exhibits high affinity, PMAT has been characterized as a low-affinity transporter, demonstrating an apparent K_m of 114 micromoles/l for serotonin, a value approximately 230 times greater than that of SERT. Nevertheless, despite its comparatively low serotonergic affinity, PMAT possesses a significantly higher transport "capacity" than SERT, leading to "roughly comparable uptake efficiencies to SERT ... in heterologous expression systems." The research further indicates that the administration of SSRIs, including fluoxetine and sertraline, might be linked to an inhibitory effect on PMAT activity when employed at dosages exceeding typical prescriptive levels (IC₅₀ test values utilized in trials were 3–4 fold higher than standard therapeutic dosages).

Serotonylation

Serotonin is also capable of signaling via a non-receptor-mediated mechanism termed serotonylation, a process where serotonin covalently modifies proteins. This mechanism is fundamental to serotonin's influence on platelet-forming cells (thrombocytes), where it is associated with the modification of signaling enzymes known as GTPases, which subsequently initiate the exocytotic release of vesicular contents. A comparable process is implicated in the pancreatic secretion of insulin.

The impact of serotonin on vascular smooth muscle tone—the biological function from which serotonin derived its original nomenclature—is contingent upon the serotonylation of proteins integral to the contractile machinery of muscle cells.

Nervous System

The raphe nuclei neurons constitute the primary origin of 5-HT release within the brain. Comprising nine distinct raphe nuclei, designated B1–B9, these structures house the majority of serotonin-containing neurons (though some researchers opt to consolidate the nuclei raphes lineares into a single nucleus). All raphe nuclei are positioned along the brainstem's midline, centered within the reticular formation. Axons originating from these raphe nuclei neurons establish a widespread neurotransmitter system that innervates nearly every region of the central nervous system. Specifically, axons from the lower raphe nuclei terminate in the cerebellum and spinal cord, whereas those from the higher nuclei project throughout the entire brain.

Neurons projecting to the central nervous system are primarily located within the dorsal region of the raphe nucleus. Serotonin-releasing neurons in this specific area receive afferent input from numerous brain regions, particularly the prefrontal cortex, lateral habenula, preoptic area, substantia nigra, and amygdala. These neurons are hypothesized to convey the anticipated value of future rewards, a metric referred to as "state value" in the context of reinforcement learning.

Ultrastructure and Function

The serotonin nuclei are categorized into two primary divisions: the rostral group, comprising three nuclei, and the caudal group, which contains four nuclei. The rostral group includes the caudal linear nuclei (B8), the dorsal raphe nuclei (B6 and B7), and the median raphe nuclei (B5, B8, and B9), all of which project to various cortical and subcortical regions. Conversely, the caudal group consists of the nucleus raphe magnus (B3), the raphe obscurus nucleus (B2), the raphe pallidus nucleus (B1), and the lateral medullary reticular formation, with projections directed towards the brainstem.

The serotonergic pathway plays a role in sensorimotor function, with projections extending to cortical (specifically from the Dorsal and Median Raphe Nuclei), subcortical, and spinal regions implicated in motor activity. Pharmacological studies indicate an increase in serotonergic activity correlating with motor engagement, while the firing rates of serotonergic neurons intensify in response to potent visual stimuli. Furthermore, animal models suggest that kainate signaling exerts a negative regulatory effect on serotonin actions within the retina, potentially influencing visual system control. The descending serotonergic projections establish a pain-inhibiting pathway, termed the "descending inhibitory pathway," which holds potential relevance for conditions such as fibromyalgia, migraine, and other pain disorders, as well as for understanding the efficacy of antidepressants in managing these conditions.

Projections originating from the caudal serotonergic nuclei are implicated in the regulation of mood and emotion. Furthermore, both hypo-serotonergic and hyper-serotonergic states are potentially associated with the pathophysiology of depression and sickness behavior.

Microanatomy

Serotonin is released into the synaptic cleft, the intercellular space between neurons, where it diffuses across a comparatively wide gap (exceeding 20 nm) to activate 5-HT receptors situated on the dendrites, cell bodies, and presynaptic terminals of neighboring neurons.

In humans, the olfactory detection of food triggers dopamine release, which subsequently enhances appetite. However, unlike in certain invertebrates, serotonin does not promote anticipatory feeding behavior in humans. Instead, serotonin released during food consumption activates 5-HT_2C receptors on dopaminergic neurons, thereby inhibiting dopamine release and consequently reducing appetite. Pharmacological agents that antagonize 5-HT_2C receptors impair the body's ability to perceive satiety or nutrient sufficiency, a phenomenon associated with weight gain, particularly in individuals exhibiting a reduced receptor count. The expression of 5-HT_2C receptors within the hippocampus demonstrates a diurnal rhythm, mirroring the serotonin release in the ventromedial nucleus, which typically peaks in the morning when the motivation to eat is most pronounced.

Studies in macaques indicate that alpha males exhibit cerebral serotonin levels twice as high as those found in subordinate males and females, as quantified by 5-HIAA concentration in the cerebrospinal fluid (CSF). This suggests a positive correlation between dominance status and CSF serotonin levels. When dominant males were removed from these social groups, subordinate males initiated competition for dominance. Following the establishment of new dominance hierarchies, the serotonin levels of the newly dominant individuals similarly doubled, reaching concentrations comparable to those observed in subordinate males and females. The specific reasons for elevated serotonin levels exclusively in dominant males, but not dominant females, remain undetermined.

In human subjects, a negative correlation has been observed between the level of 5-HT_1A receptor inhibition in the brain and aggression. Furthermore, a specific mutation in the gene encoding the 5-HT_2A receptor may double the risk of suicide for individuals possessing this genotype. Cerebral serotonin is typically not degraded post-synaptically but is instead reabsorbed by serotonergic neurons via serotonin transporters located on their cell surfaces. Research indicates that approximately 10% of the total variance in anxiety-related personality traits is attributable to variations in the regulatory mechanisms governing the location, timing, and quantity of serotonin transporter deployment by neurons.

Outside the Nervous System

Digestive Tract (Emetic)

Serotonin plays a crucial role in regulating gastrointestinal (GI) function. Enterochromaffin cells, which line the gut, release serotonin in response to the presence of food within the lumen, thereby inducing gut contractions around the ingested material. Excess serotonin is subsequently collected by platelets within the veins draining the gastrointestinal tract. Serotonin abnormalities are frequently observed in various gastrointestinal disorders, including constipation and irritable bowel syndrome.

The presence of irritants in ingested food prompts enterochromaffin cells to augment serotonin release, accelerating gut motility and inducing diarrhea to expel harmful substances. An elevated rate of serotonin release into the bloodstream, exceeding platelet absorption capacity, results in increased circulating free serotonin levels. This excess serotonin activates 5-HT3 receptors within the chemoreceptor trigger zone, thereby stimulating emesis. Consequently, various pharmaceutical agents and toxins can induce emesis by stimulating serotonin secretion from enterochromaffin cells in the intestinal wall. Beyond dietary irritants, enterochromaffin cells exhibit significant sensitivity to irradiation and chemotherapeutic agents. Pharmacological antagonists of 5-HT3 receptors are highly efficacious in managing chemotherapy-induced nausea and vomiting, establishing them as the benchmark treatment for this condition.

Lungs

The pulmonary system, including that of reptiles, contains specialized epithelial cells. These cells manifest either individually or as aggregates, designated as neuroepithelial bodies, bronchial Kulchitsky cells, or K cells. Functionally, these are enterochromaffin cells, analogous to those in the gastrointestinal tract, which secrete serotonin. Their probable physiological role involves mediating vasoconstriction during hypoxic conditions.

Skin

Merkel cells, integral components of the somatosensory system, also synthesize serotonin.

Bone metabolism

In both murine models and human subjects, modifications in serotonin levels and signaling pathways have been demonstrated to regulate bone mass. Mice deficient in brain serotonin exhibit osteopenia, whereas those lacking gut serotonin display elevated bone density. In humans, elevated circulating serotonin levels are a significant negative predictor of reduced bone density. Serotonin can also be synthesized, albeit in minimal quantities, within osteocytes. Its actions on bone cells are mediated via three distinct receptors: 5-HT_1B receptors negatively regulate bone mass, while 5-HT_2B and 5-HT_2C receptors exert positive regulatory effects. A delicate equilibrium exists between the physiological functions of gut serotonin and its pathological implications. Elevated extracellular serotonin concentrations initiate a complex signaling cascade within osteoblasts, culminating in FoxO1/Creb and ATF4-dependent transcriptional events. Subsequent to the 2008 discovery of gut serotonin's role in bone mass regulation, mechanistic investigations into the factors governing intestinal serotonin synthesis and its impact on bone density have commenced. Piezo1 has been identified as a gut-based sensor for single-stranded RNA (ssRNA), relaying this information to the bone via serotonin synthesis, thereby regulating 5-HT production. Intestinal epithelium-specific deletion of murine Piezo1 significantly impaired gut peristalsis, attenuated experimental colitis, and reduced serum 5-HT levels. The resulting systemic 5-HT deficiency in conditional Piezo1 knockout models led to increased bone formation. Furthermore, fecal ssRNA was identified as an endogenous Piezo1 ligand, and ssRNA-induced 5-HT synthesis from the gut occurred independently of MyD88/TRIF pathways. Colonic administration of RNase A suppressed intestinal motility and augmented bone mass. These collective findings position gut ssRNA as a primary determinant of systemic 5-HT levels, highlighting the ssRNA-Piezo1 axis as a prospective prophylactic target for managing both bone and gastrointestinal disorders. Research conducted in 2008, 2010, and 2019 has expanded the potential for serotonin-focused investigations into the treatment of bone mass disorders.

Organ development

Given serotonin's role in signaling resource availability, its influence on organ development is physiologically expected. Numerous human and animal investigations have demonstrated that early-life nutrition can significantly impact adult phenotypes, including body adiposity, lipid profiles, blood pressure, atherosclerosis susceptibility, behavior, cognitive function, and lifespan. Rodent studies indicate that neonatal exposure to selective serotonin reuptake inhibitors (SSRIs) induces lasting alterations in cerebral serotonergic transmission, leading to behavioral modifications that can be ameliorated by antidepressant treatment. Through experiments involving both wild-type and serotonin transporter-deficient mice treated with fluoxetine, researchers demonstrated that typical adult emotional responses, such as rapid escape from foot shocks and exploratory behavior in novel environments, are contingent upon active serotonin transporters during the neonatal stage.

Human serotonin functions directly as a growth factor. Hepatic injury elevates the cellular expression of 5-HT_2A and 5-HT_2B receptors, which mediates compensatory liver regeneration. Subsequently, circulating serotonin stimulates cellular proliferation to facilitate hepatic repair.

The 5-HT_2B receptors activate osteocytes, which are responsible for bone formation. Conversely, serotonin also inhibits osteoblasts via 5-HT_1B receptors.

Cardiovascular Growth Factor

Furthermore, serotonin induces endothelial nitric oxide synthase activation and, through a 5-HT1B receptor-mediated pathway, stimulates the phosphorylation of p44/p42 mitogen-activated protein kinase in bovine aortic endothelial cell cultures. Within the bloodstream, platelets sequester and store serotonin from plasma. Consequently, serotonin exerts its effects wherever platelets aggregate in compromised tissue, acting as a vasoconstrictor to halt hemorrhage and as a fibrocyte mitotic agent (growth factor) to promote tissue repair.

Adipose Tissue

Serotonin modulates the function of both white and brown adipose tissue, with adipocytes independently synthesizing 5-HT distinct from gut production. Specifically, serotonin enhances lipogenesis in white adipose tissue via HTR2A and suppresses thermogenesis in brown adipose tissue through Htr3.

Pharmacology

Numerous pharmacological agents target the serotonergic system, encompassing categories such as antidepressants, anxiolytics, antipsychotics, analgesics, antimigraine medications, oxytocics, antiemetics, appetite suppressants, and anticonvulsants, in addition to psychedelics and entactogens.

Mechanism of Action

In a quiescent state, serotonin resides within the vesicles of presynaptic neurons. Upon stimulation by nerve impulses, serotonin is liberated into the synaptic cleft as a neurotransmitter, where it reversibly binds to postsynaptic receptors, thereby eliciting a nerve impulse in the postsynaptic neuron. Serotonin can also engage with autoreceptors on the presynaptic neuron, modulating its own synthesis and release. Typically, serotonin is reabsorbed into the presynaptic neuron to terminate its action, subsequently undergoing reuse or degradation by monoamine oxidase.

Antidepressants

Pharmacological agents that modulate serotonin levels are employed in the treatment of depression, generalized anxiety disorder, and social phobia. Monoamine oxidase inhibitors (MAOIs) impede the degradation of monoamine neurotransmitters, including serotonin, thereby elevating their cerebral concentrations. MAOI therapy is linked to numerous adverse drug reactions, and patients face a risk of hypertensive crisis precipitated by foods rich in tyramine and specific medications. Other drugs impede serotonin reuptake, prolonging its presence in the synaptic cleft. Tricyclic antidepressants (TCAs) inhibit the reuptake of both serotonin and norepinephrine. Newer selective serotonin reuptake inhibitors (SSRIs) exhibit a more favorable side-effect profile and fewer drug interactions.

Despite initial elevations, some SSRI medications have been observed to reduce serotonin levels below baseline following chronic administration. The 5-HTTLPR gene encodes for the quantity of serotonin transporters in the brain; an increased number of these transporters results in a diminished duration and magnitude of serotonergic signaling. The 5-HTTLPR polymorphism (l/l), which leads to the formation of more serotonin transporters, is also associated with enhanced resilience against depression and anxiety.

Beyond their application in managing depression and anxiety, specific serotonergic antidepressants are also approved and utilized for the treatment of fibromyalgia, neuropathic pain, and chronic fatigue syndrome.

Anxiolytics

Azapirone anxiolytics, such as buspirone and tandospirone, function as agonists for the serotonin 5-HT_1A receptor.

Antipsychotics

A substantial number of antipsychotic medications interact with and modulate various serotonin receptors, including, but not limited to, the serotonin 5-HT_1A, 5-HT_2A, 5-HT_2B, 5-HT_2C, 5-HT§8_{9§, and 5-HT§10}11§ receptors. The activation of serotonin 5-HT_1A receptors and the blockade of serotonin 5-HT_2A receptors are hypothesized to contribute to the therapeutic antipsychotic efficacy of these compounds, while antagonism of serotonin 5-HT_2C receptors has been particularly associated with their adverse effects.

Antimigraine Agents

Pharmacological interventions for migraine, including triptans such as sumatriptan, function as agonists for the serotonin 5-HT_1B, 5-HT_1D, and/or 5-HT_1F receptors. Historically, antimigraine treatments included ergoline derivatives and related ergot compounds, specifically ergotamine, dihydroergotamine, and methysergide, which operate as non-selective agonists of serotonin receptors.

Oxytocics

Specific lysergamide compounds, such as ergometrine and methylergometrine, find clinical application as oxytocic agents. Their oxytocic actions are hypothesized to primarily result from the agonistic activity at serotonin 5-HT₂ receptors located within uterine smooth muscle tissue.

Antiemetics

Certain serotonin 5-HT₃ receptor antagonists, including ondansetron, granisetron, and tropisetron, serve as significant antiemetic agents. These agents are especially crucial for managing nausea and emesis associated with cytotoxic anticancer chemotherapy. Additionally, they are employed in the management of postoperative nausea and vomiting.

Appetite suppressants

A class of compounds, encompassing serotonin releasing agents, serotonin reuptake inhibitors, and/or serotonin 5-HT_2C receptor agonists, including fenfluramine, dexfenfluramine, chlorphentermine, sibutramine, and lorcaserin, have received approval and been utilized as appetite suppressants to facilitate weight reduction in individuals with overweight or obesity. However, several of these agents have subsequently been withdrawn from commercial availability due to documented toxicities, specifically cardiac fibrosis or pulmonary hypertension.

Anticonvulsants

Despite its prior market withdrawal as an appetite suppressant, fenfluramine has been reintroduced as an anticonvulsant for managing seizures in specific rare epileptic syndromes, such as Dravet syndrome and Lennox–Gastaut syndrome. Furthermore, selective serotonin 5-HT_2C receptor agonists, including lorcaserin, bexicaserin, and BMB-101, are currently under development for similar therapeutic applications.

Psychedelics

Serotonergic psychedelic compounds, such as psilocybin (present in psilocybin mushrooms), dimethyltryptamine (DMT) (a component of ayahuasca), lysergic acid diethylamide (LSD), mescaline (derived from peyote cactus), and 5-MeO-DMT (identified in Anadenanthera trees and the Bufo alvarius toad), function as non-selective agonists of serotonin receptors, with their hallucinogenic properties primarily mediated through the activation of the serotonin 5-HT_2A receptor. This mechanism is supported by evidence demonstrating that serotonin 5-HT_2A receptor antagonists, including compounds colloquially termed "trip killers" such as ketanserin, inhibit the hallucinogenic effects of serotonergic psychedelics in human subjects, alongside numerous other corroborating observations. Certain serotonergic psychedelics, specifically psilocin, DMT, and 5-MeO-DMT, are classified as substituted tryptamines and exhibit significant structural homology with serotonin.

Despite functioning as a serotonin 5-HT_2A receptor agonist, serotonin itself is considered non-hallucinogenic. The hallucinogenic actions of serotonergic psychedelics are hypothesized to arise from the activation of serotonin 5-HT_2A receptors located within a specific population of cortical neurons in the medial prefrontal cortex (mPFC). Notably, these serotonin 5-HT_2A receptors, in contrast to the majority of serotonin and related receptors, exhibit intracellular expression. Furthermore, the neurons housing these receptors do not express the serotonin transporter (SERT), which typically facilitates the uptake of serotonin from the extracellular to the intracellular neuronal compartments. Consequently, serotonin, being highly hydrophilic, cannot readily penetrate serotonergic neurons in the absence of SERT, rendering these serotonin 5-HT_2A receptors inaccessible to endogenous serotonin. In contrast, serotonergic psychedelics possess greater lipophilicity than serotonin, enabling their facile entry into these neurons. Beyond elucidating the absence of psychedelic effects from serotonin, these observations may also account for why agents that elevate serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs) and other serotonergic compounds, do not induce psychedelic experiences. Experimental induction of SERT expression in these medial prefrontal cortex neurons enabled the serotonin releasing agent para-chloroamphetamine (PCA), which typically lacks psychedelic-like effects, to elicit such effects in animal models.

While serotonin itself does not induce hallucinogenic effects, the administration of exceptionally high doses of its precursors, such as tryptophan or 5-hydroxytryptophan (5-HTP), or the direct intracerebroventricular injection of substantial serotonin quantities into the brain, has been observed to elicit psychedelic-like responses in animal models. These psychedelic manifestations can be mitigated by indolethylamine N-methyltransferase (INMT) inhibitors, which impede the bioconversion of serotonin and other endogenous tryptamines into N-methylated tryptamines. Such methylated compounds include N-methylserotonin (NMS; norbufotenin), bufotenin (5-hydroxy-N,N-dimethyltryptamine; 5-HO-DMT), N-methyltryptamine (NMT), and N,N-dimethyltryptamine (DMT). Notably, these N-methyltryptamines exhibit significantly greater lipophilicity compared to serotonin, enabling their diffusion into serotonergic neurons and subsequent activation of intracellular serotonin 5-HT_2A receptors. Furthermore, 5-methoxytryptamine (5-MT) represents another potential serotonin metabolite capable of inducing psychedelic-like effects in animals.

As an endogenous compound naturally present within the body, DMT is hypothesized to serve as the physiological ligand for intracellular serotonin 5-HT_2A receptors, particularly considering that serotonin itself lacks the capacity to activate these specific receptors.

Entactogens

MDMA, an entactogen, functions primarily as a serotonin releasing agent. Although it also exhibits additional pharmacological properties, including the concurrent release of norepinephrine and dopamine, alongside weak direct agonism at serotonin 5-HT₂ receptors, the release of serotonin is pivotal for its distinctive entactogenic effects. Entactogens, exemplified by MDMA, necessitate differentiation from other pharmacological classes such as stimulants (e.g., amphetamine) and psychedelics (e.g., LSD), despite MDMA possessing certain characteristics shared with both categories of agents. The coadministration of selective serotonin reuptake inhibitors (SSRIs), which inhibit the serotonin transporter (SERT) and thus preclude MDMA from inducing serotonin release, significantly diminishes the subjective effects of MDMA, thereby underscoring the critical involvement of serotonin in the drug's actions. Serotonin releasing agents, such as MDMA, elicit substantially greater elevations in serotonin concentrations compared to SSRIs, resulting in more pronounced subjective experiences. Beyond MDMA, numerous other entactogenic compounds are recognized.

Serotonin Syndrome

Elevated serotonin levels or the activation of specific serotonin receptors can precipitate serotonin syndrome, a condition characterized by toxic and potentially lethal outcomes. Clinically, achieving such hazardous concentrations is generally improbable through an overdose of a solitary antidepressant medication; rather, it typically necessitates the concurrent administration of multiple serotonergic agents, such as an SSRI combined with a MAOI, even within therapeutic dosage ranges. Nevertheless, serotonin syndrome can also manifest following an overdose of particular serotonin receptor agonists, including compounds from the NBOMe series of serotonergic psychedelics.

The clinical manifestations of serotonin syndrome exhibit a broad spectrum of intensity, with milder presentations observed even at non-toxic serotonin concentrations. Estimates suggest that 14% of patients diagnosed with serotonin syndrome have overdosed on SSRIs, and the associated fatality rate ranges from 2% to 12%.

Cardiac Fibrosis and Other Fibroses

Certain serotonergic agonist medications are implicated in inducing fibrosis throughout the body, notably manifesting as retroperitoneal fibrosis syndrome and cardiac valve fibrosis.

Historically, epidemiological studies have established a correlation between these fibrotic syndromes and three distinct classes of serotonergic drugs. These categories encompass serotonergic vasoconstrictive antimigraine agents (e.g., ergotamine and methysergide), serotonergic appetite suppressants (e.g., fenfluramine, chlorphentermine, and aminorex), and specific anti-Parkinsonian dopaminergic agonists that also activate serotonergic 5-HT_2B receptors. Examples of the latter include pergolide and cabergoline, in contrast to the more dopamine-selective compound, lisuride.

Similar to fenfluramine, several of these medications have been withdrawn from commercial availability following observations of a statistically significant increase in one or more of the aforementioned adverse effects among patient populations. Pergolide serves as a pertinent illustration; its utilization diminished considerably after reports in 2003 linked it to the development of cardiac fibrosis.

In January 2007, two independent studies published in The New England Journal of Medicine linked pergolide and cabergoline to the development of valvular heart disease. Consequently, the FDA withdrew pergolide from the United States market in March 2007. Cabergoline, however, remained available because its approval in the United States is for hyperprolactinemia, not Parkinson's Disease, and the lower doses required for hyperprolactinemia treatment mitigate the risk of valvular heart disease.

Comparative Biology and Evolution

Unicellular Organisms

Serotonin serves diverse functions in various single-cell organisms. Selective serotonin reuptake inhibitors (SSRIs) have demonstrated toxicity to algae. The gastrointestinal parasite Entamoeba histolytica secretes serotonin, which can induce persistent secretory diarrhea in certain individuals. Infected patients exhibit significantly elevated serum serotonin levels, which normalize upon resolution of the infection. Furthermore, E. histolytica increases its virulence in response to serotonin. This serotonin secretion not only facilitates the spread of entamoebas through host-induced diarrhea but also coordinates their behavior based on population density, a process termed quorum sensing. Outside a host's gut, entamoebas do not stimulate serotonin release, resulting in very low serotonin concentrations. Low serotonin levels signal to entamoebas that they are outside a host, prompting them to reduce virulence to conserve energy. Upon entering a new host, they proliferate within the gut, and their virulence increases as enterochromaffin cells are stimulated, leading to elevated serotonin concentrations.

Edible Plants and Fungi

In drying seeds, serotonin synthesis serves to eliminate accumulated toxic ammonia. Ammonia is incorporated into the indole moiety of L-tryptophan, which subsequently undergoes decarboxylation by tryptophan decarboxylase to form tryptamine. Tryptamine is then hydroxylated by a cytochrome P450 monooxygenase, ultimately yielding serotonin.

Furthermore, as a significant modulator of the gastrointestinal tract, serotonin may be synthesized in plant fruits to accelerate seed transit through the digestive system, analogous to the action of various established seed- and fruit-derived laxatives. Serotonin is present in fungi, fruits, and vegetables. Concentrations ranging from 25 to 400 mg/kg, representing the highest values, have been detected in nuts from the walnut (Juglans) and hickory (Carya) genera. Serotonin levels between 3 and 30 mg/kg have been identified in plantains, pineapples, bananas, kiwifruit, plums, and tomatoes. A broad spectrum of tested vegetables contains moderate serotonin concentrations, typically from 0.1 to 3 mg/kg.

Serotonin is a constituent of the venom found in stinging nettles (Urtica dioica), where its injection elicits pain, similar to its role in insect venoms. Additionally, it occurs naturally in Paramuricea clavata, commonly known as the Red Sea Fan.

Serotonin and tryptophan have been detected in chocolate, with their concentrations varying based on cocoa content. The highest serotonin concentration (2.93 μg/g) was observed in chocolate containing 85% cocoa, while the peak tryptophan content (13.27–13.34 μg/g) was found in chocolate with 70–85% cocoa. Notably, 5-hydroxytryptophan, an intermediate in the tryptophan-to-serotonin synthesis pathway, was not identified.

Serotonin stimulates and modulates root development in Arabidopsis thaliana, exhibiting diverse effects dependent on its concentration.

Serotonin functions as a phytochemical defense mechanism against fungal pathogens in plants. Upon infection with Fusarium crown rot, caused by Fusarium pseudograminearum, wheat (Triticum aestivum) significantly upregulates tryptophan biosynthesis, leading to increased serotonin production. While the precise role of this response remains largely uncharacterized, wheat also synthesizes serotonin during infection by Stagonospora nodorum, where it has been observed to inhibit spore development. The model cereal Brachypodium distachyon, frequently employed as a surrogate for wheat and other cultivated cereals in research, similarly generates serotonin, coumaroyl-serotonin, and feruloyl-serotonin when exposed to F. graminearum. This synthesis confers a modest antimicrobial effect. Notably, B. distachyon exhibits elevated production of serotonin and its conjugates in response to deoxynivalenol (DON)-producing strains of F. graminearum compared to non-DON-producing strains. Furthermore, Solanum lycopersicum synthesizes numerous amino acid conjugates, including several serotonin derivatives, within its leaves, stems, and roots following infection by Ralstonia solanacearum.

Serotonin is present in various hallucinogenic mushrooms belonging to the genus Panaeolus.

Invertebrate Systems

Serotonin operates as a neurotransmitter within the nervous systems of the majority of animal species.

Nematode Physiology

For instance, in the bacterivorous roundworm Caenorhabditis elegans, serotonin is secreted as a signaling molecule in response to favorable stimuli, such as the discovery of a novel food source or the encounter between a male and a potential mate. When a satiated worm detects bacteria on its cuticle, dopamine release induces a reduction in locomotion; conversely, in starved individuals, serotonin is additionally released, further attenuating the animal's movement. This dual mechanism prolongs the duration an animal spends in proximity to food resources. Secreted serotonin stimulates feeding-related musculature, whereas octopamine exerts an inhibitory effect on these same muscles. Serotonin subsequently diffuses to specific serotonin-sensitive neurons, which regulate the animal's perception of nutrient abundance.

Decapod Crustaceans

Experimental injection of serotonin into lobsters elicits behaviors characteristic of dominant individuals, while octopamine induces subordinate behaviors. In crayfish, a fright response may involve a tail-flip escape maneuver; the influence of serotonin on this behavior is significantly modulated by the animal's social hierarchy. Specifically, serotonin suppresses the escape reaction in subordinate crayfish but augments it in socially dominant or isolated specimens. This differential effect is attributed to social experience, which modifies the relative expression of serotonin receptors (5-HT receptors) that exert antagonistic influences on the fight-or-flight response. The activity of 5-HT₁ receptors is predominant in subordinate animals, whereas 5-HT₂ receptors exert a greater influence in dominant individuals.

Presence in Venoms

Serotonin is a ubiquitous constituent found in invertebrate venoms, salivary glands, nervous tissues, and diverse other tissues across phyla including molluscs, insects, crustaceans, scorpions, various annelids, and cnidarians. Adult Rhodnius prolixus, a hematophagous insect that feeds on vertebrates, secretes lipocalins into the host wound during its feeding process. In 2003, these lipocalins were shown to sequester serotonin, thereby preventing vasoconstriction and potentially inhibiting coagulation in the host organism.

Insect Neurobiology

Serotonin is an evolutionarily conserved molecule, present throughout the animal kingdom. In insects, it participates in physiological processes analogous to those in the human central nervous system, including memory formation, appetite regulation, sleep cycles, and behavioral modulation. Specific neural circuits within the mushroom bodies exhibit serotonergic activity.

Acrididae (Locusts)

Locust swarming behavior is initiated, though not sustained, by serotonin, with its release prompted by tactile interactions among individuals. This neurochemical shift alters social preference from aversion to a gregarious state, facilitating the formation of cohesive groups. Furthermore, the presence of serotonin influences learning processes in both flies and honeybees.

Implications for Insecticides

Insect 5-HT receptors exhibit sequence homology with their vertebrate counterparts; however, notable pharmacological distinctions have been observed. The pharmacological responses of invertebrate systems are considerably less characterized than those of mammalian systems, prompting discussions regarding the potential for developing species-selective insecticides targeting these differences.

Hymenopteran Biology

The venom of wasps and hornets, similar to that of scorpions, contains serotonin, which induces pain and inflammation. As Pheidole dentata ants age, they assume an increasing number of colony tasks, necessitating heightened responsiveness to a broader range of olfactory cues. Research in 2006 indicated that this expansion of olfactory responsiveness correlated with elevated levels of serotonin and dopamine, but not octopamine.

Dipterans

Serotonin administration enhances aggression in flies, while serotonin depletion reduces the frequency of aggressive behaviors, though not eliminating them entirely. Within their crops, serotonin is crucial for digestive motility, facilitating contractions. The serotonin influencing crop function is exogenous to the crop; a 2012 study proposed its likely origin within the serotonin neural plexus of the thoracic-abdominal synganglion. In 2011, a serotonergic mushroom body in Drosophila was identified as collaborating with Amnesiac in memory formation. A 2007 study revealed that serotonin promotes aggression in Diptera, an effect mitigated by neuropeptide F. This finding was unexpected, considering that both substances typically facilitate courtship, which often shares similarities with aggression.

Vertebrates

Serotonin, chemically known as 5-hydroxytryptamine (5-HT), is a neurotransmitter primarily recognized for its role in human mood disorders. Furthermore, it functions as a pervasive neuromodulator across both vertebrate and invertebrate species. Serotonin has been implicated in numerous physiological systems, encompassing cardiovascular regulation, thermoregulation, and various behavioral functions, such as circadian rhythm, appetite, aggressive and sexual behaviors, sensorimotor reactivity, learning, and pain sensitivity. The role of serotonin within neurological systems and its strong association with specific vertebrate behaviors will be elaborated upon. Additionally, two pertinent case studies concerning serotonin development in teleost fish and mice will be presented.

Within mammals, 5-HT exhibits high concentrations in the substantia nigra, ventral tegmental area, and raphe nuclei. Lower concentrations are observed in other brain regions and the spinal cord. Mammalian 5-HT neurons are notably highly branched, suggesting a structural prominence that enables simultaneous influence over multiple central nervous system (CNS) areas; however, this morphological characteristic is unique to mammals.

5-HT system in vertebrates

Vertebrates are multicellular organisms belonging to the phylum Chordata, characterized by the presence of a backbone and a nervous system. This classification encompasses mammals, fish, reptiles, and birds, among others. While the human nervous system comprises central and peripheral components, the precise mechanisms of neurotransmitters in most other vertebrates remain largely uncharacterized. Nevertheless, serotonin is recognized for its involvement in stress and behavioral responses, as well as its significance in cognitive functions. The brain organization of most vertebrates features 5-HT cells located in the hindbrain. Furthermore, in non-placental vertebrates, 5-HT is frequently detected in additional brain regions, such as the basal forebrain and pretectum. Given that the localization of serotonin receptors influences behavioral responses, it is hypothesized that serotonin participates in distinct pathways in non-placental vertebrates that are absent in amniotic organisms. Teleost fish and mice are frequently employed model organisms for investigating the relationship between serotonin and vertebrate behavior. While both organisms exhibit comparable behavioral effects of serotonin, the underlying mechanisms of these responses diverge.

Canine species

Research on serotonin in canine species is limited. A single study indicated higher serotonin levels during dawn compared to dusk. Conversely, another investigation found no apparent association between serum 5-HT levels and canine behavioral responses to stressful stimuli. The urinary serotonin-to-creatinine ratio in female dogs demonstrated an upward trend four weeks post-surgery. Furthermore, following ovariohysterectomy, serotonin exhibited a positive correlation with both cortisol and progesterone, but not with testosterone.

Teleost fish

Similar to non-placental vertebrates, teleost fish also possess 5-HT cells in various brain regions, including the basal forebrain. Danio rerio (zebrafish) is a teleost species frequently utilized for investigating cerebral serotonin. Despite significant gaps in understanding serotonergic systems in vertebrates, their importance in moderating stress and social interaction is well-established. It is hypothesized that arginine vasotocin (AVT) and corticotropin-releasing factor (CRF) collaborate with serotonin within the hypothalamic-pituitary-interrenal axis. These neuropeptides influence teleost plasticity, thereby affecting the organism's capacity for adaptation and environmental responsiveness. Subordinate fish in social hierarchies exhibit a significant elevation in 5-HT concentrations. Persistently high levels of 5-HT are associated with the long-term inhibition of aggression in subordinate fish.

Mice

Researchers at the Department of Pharmacology and Medical Chemistry administered serotonergic drugs to male mice to examine their behavioral effects. Mice housed in isolation typically display heightened levels of agonistic behavior towards conspecifics. The study's findings indicated that serotonergic drugs reduced aggression in isolated mice while concurrently enhancing social interaction. Although each treatment employed a distinct mechanism for targeting aggression, all ultimately yielded the same outcome. While the study demonstrated that serotonergic drugs successfully targeted serotonin receptors, it did not elucidate the specific mechanisms by which these drugs influenced behavior, as all types consistently reduced aggression in isolated male mice. Aggressive mice not subjected to isolation may exhibit different responses to alterations in serotonin reuptake.

Behavior

Similar to its role in humans, serotonin is integral to regulating behavior across most other vertebrate species. This regulatory function encompasses not only response and social behaviors but also the modulation of mood. Dysfunctions within serotonergic pathways can lead to pronounced fluctuations in mood, as well as symptoms characteristic of mood disorders, which are observable in a broader range of species beyond humans.

Social interaction

Aggression represents a highly investigated dimension of social interaction influenced by serotonin. The 5-HT system regulates aggression, as serotonin levels can either induce or inhibit aggressive behaviors, a phenomenon observed in species such as mice and crabs. While this regulatory role is well-established, the precise nature of serotonin's interaction (direct or indirect) with brain regions governing aggression and other behaviors remains unclear. Studies on serotonin levels reveal significant fluctuations during social interactions, which typically correlate with either the inhibition or provocation of aggressive conduct. The specific mechanisms by which serotonin influences social behaviors are not fully elucidated, given the considerable variability in 5-HT system pathways across different vertebrate species.

Response to stimuli

Serotonin plays a crucial role in environmental response pathways, alongside other neurotransmitters. Specifically, it has been implicated in auditory processing within social contexts, given the interconnectedness of primary sensory systems and social interactions. Serotonin is localized within the inferior colliculus (IC) structure of the midbrain, which is responsible for processing both species-specific and non-specific social interactions and vocalizations. The IC also receives acoustic projections that transmit signals to auditory processing regions. Research suggests that serotonin modulates the auditory information received by the IC, consequently influencing responses to auditory stimuli. This modulation can impact an organism's behavioral responses to auditory cues from predatory or other significant species in their environment, as serotonin uptake can influence aggression or social interaction.

Mood

Mood is characterized not by a specific emotional status, but rather by its association with a relatively enduring emotional state. Serotonin's role in mood regulation is prominently recognized in human conditions such as various forms of depression and bipolar disorders. Dysfunctions stemming from serotonergic activity may contribute to numerous symptoms of major depression, including alterations in general mood, activity levels, suicidal ideation, and sexual and cognitive impairments. Selective serotonin reuptake inhibitors (SSRIs) constitute a class of pharmaceuticals proven effective in treating major depressive disorder and represent the most frequently prescribed category of antidepressants. SSRIs operate by inhibiting serotonin reuptake, thereby increasing the availability of serotonin for absorption by postsynaptic neurons. Research involving animal models has been conducted for decades to elucidate depressive behaviors across species. A notable investigation, the forced swimming test (FST), was employed to assess potential antidepressant efficacy. In this test, rats were placed in an inescapable water container, and their immobility duration and active behaviors (e.g., splashing or climbing) were quantified and compared before and after the administration of various antidepressant drugs. Antidepressants that specifically inhibit norepinephrine (NE) reuptake were observed to decrease immobility and selectively enhance climbing, without influencing swimming behavior. Conversely, SSRIs also demonstrated reduced immobility but increased swimming, without affecting climbing. This research underscored the significance of behavioral assays for antidepressant evaluation, as they can identify compounds impacting both fundamental behaviors and species-specific behavioral components.

Growth and Reproduction

In the nematode C. elegans, artificial depletion of serotonin or an increase in octopamine levels elicits behaviors characteristic of a low-food environment: C. elegans becomes more active, and both mating and egg-laying are suppressed. Conversely, an elevation in serotonin or a reduction in octopamine in this organism produces the opposite effects. Serotonin is indispensable for typical male nematode mating behavior and for the propensity to depart from food sources in pursuit of a mate. The serotonergic signaling mechanisms that facilitate the worm's behavioral adaptation to rapid environmental shifts influence insulin-like signaling and the TGF beta signaling pathway, both of which govern long-term adaptation processes.

In the fruit fly, insulin regulates blood sugar and also functions as a growth factor. Consequently, serotonergic neurons in the fruit fly modulate adult body size by influencing insulin secretion. Serotonin has also been identified as the trigger for swarm behavior in locusts. In humans, while insulin governs blood sugar and insulin-like growth factor (IGF) regulates growth, serotonin controls the release of both hormones, modulating insulin release from pancreatic beta cells through the serotonylation of GTPase signaling proteins. Exposure to selective serotonin reuptake inhibitors (SSRIs) during gestation has been associated with reduced fetal growth.

Genetically modified C. elegans worms deficient in serotonin exhibit an extended reproductive lifespan, may develop obesity, and occasionally display arrested development at a dormant larval stage.

Aging and Age-Related Phenotypes

Serotonin is recognized for its regulatory roles in aging, learning, and memory. Initial evidence supporting this function emerged from longevity studies conducted on C. elegans. During the early stages of aging, serotonin levels increase, leading to alterations in locomotory behaviors and associative memory. This effect can be reversed by mutations and pharmacological agents (such as mianserin and methiothepin) that inhibit serotonin receptors. This finding is not inconsistent with the observation that serotonin levels typically decline in mammals and humans during the later, but not early, phases of aging.

Biochemical Mechanisms

Biosynthesis

In both animals and humans, serotonin is synthesized from the amino acid L-tryptophan via a concise metabolic pathway involving two enzymes, tryptophan hydroxylase (TPH) and aromatic amino acid decarboxylase (DDC), along with the coenzyme pyridoxal phosphate. The reaction catalyzed by TPH represents the rate-limiting step within this biosynthetic pathway.

Tryptophan hydroxylase (TPH) has been identified in two distinct isoforms: TPH1, which is present in various tissues, and TPH2, an isoform specific to neurons.

Laboratory synthesis of serotonin from tryptophan can be achieved using Aspergillus niger and Psilocybe coprophila as catalytic agents. The initial stage, converting tryptophan to 5-hydroxytryptophan, involves incubating tryptophan in an ethanol-water solution for seven days. Subsequently, hydrochloric acid (or another suitable acid) is introduced to adjust the pH to 3, followed by the addition of sodium hydroxide to achieve a pH of 13 for one hour. Aspergillus niger serves as the catalyst for this first phase. The subsequent phase, synthesizing serotonin from the 5-hydroxytryptophan intermediate, necessitates the addition of ethanol and water, followed by a 30-day incubation period. The next two steps mirror those of the first phase: adjusting the pH to 3 with hydrochloric acid, then raising it to a highly basic pH of 13 with sodium hydroxide for one hour. This particular reaction phase is catalyzed by Psilocybe coprophila.

Orally administered serotonin is unable to permeate the blood–brain barrier, thereby preventing its entry into the central nervous system's serotonergic pathways. Conversely, tryptophan and its metabolite 5-hydroxytryptophan (5-HTP), precursors to serotonin synthesis, are capable of traversing the blood–brain barrier. These compounds are accessible through dietary supplements and various food sources, potentially acting as effective serotonergic agents.

The metabolic degradation of serotonin yields 5-hydroxyindoleacetic acid (5-HIAA), which is subsequently eliminated via urinary excretion. Certain neoplastic conditions, such as tumors or cancers, can lead to the overproduction of serotonin and 5-HIAA. Consequently, urinary levels of these compounds can be quantified to aid in the detection of such malignancies.

Analytical chemistry

Indium tin oxide is a recommended electrode material for electrochemical investigations involving concentrations of substances produced, detected, or consumed by microbial organisms. In 1994, a mass spectrometry technique was developed specifically for determining the molecular weight of both naturally occurring and synthetically produced serotonins.

History and etymology

For more than a century, physiologists had observed the presence of a vasoconstrictive substance in serum following blood coagulation. In 1935, Vittorio Erspamer, an Italian researcher based in Pavia, demonstrated that an extract derived from enterochromaffin cells induced intestinal contractions. Initially, some hypothesized the presence of adrenaline; however, two years later, Erspamer conclusively identified it as a novel amine, which he designated "enteramine." Subsequently, in 1948, Maurice M. Rapport, Arda Green, and Irvine Page at the Cleveland Clinic isolated a vasoconstrictive compound from blood serum. Given its role as a serum-derived agent influencing vascular tone, they termed it serotonin.

By 1952, enteramine was identified as identical to serotonin. As its diverse physiological functions became apparent, the abbreviation 5-HT, derived from its chemical name 5-hydroxytryptamine, gained prominence in pharmacology. Alternative designations for serotonin encompass 5-hydroxytryptamine, enteramine, substance DS, and 3-(β-aminoethyl)-5-hydroxyindole. Betty Twarog and Page subsequently identified serotonin within the central nervous system in 1953. Page acknowledged Erspamer's research on Octopus vulgaris, Discoglossus pictus, Hexaplex trunculus, Bolinus brandaris, Sepia, Mytilus, and Ostrea as foundational for comprehending this newly characterized substance. However, he considered Erspamer's earlier findings from various models, particularly those involving rat blood, to be overly complicated by the co-occurrence of other bioactive compounds, including additional vasoactive agents.

Effects in humans

Oral administration of serotonin at a dose of 100mg in humans elicited various effects, including alterations in blood pressure, abdominal cramping, myalgia, and a sensation of sedation. Notably, unlike psychedelic compounds such as LSD, no hallucinogenic effects were documented. Furthermore, other investigations demonstrated that low intravenous doses of serotonin, ranging from 2 to 6mg, did not impact human electroencephalogram (EEG) readings. Consistent with these observations, it has been asserted that serotonin administration in humans does not induce psychoactive effects beyond those attributable to anxiety, which may arise from its significant peripheral adverse reactions, such as circulatory disturbances, other autonomic effects, and emesis. While intracerebroventricular serotonin injection has been explored in individuals with severe psychiatric disorders, comprehensive data regarding its psychoactive properties remain limited.

Exogenous serotonin is hypothesized to be excessively hydrophilic, impeding its passage across the blood-brain barrier, and exhibits insufficient metabolic stability due to rapid degradation by monoamine oxidase (MAO), thereby precluding the induction of central drug-like effects in humans following peripheral administration. In contrast, numerous closely related serotonin analogues, characterized by enhanced lipophilicity and metabolic stability—such as bufotenin (N,N-dimethylserotonin), 5-MeO-DMT (N,N,O-trimethylserotonin), and 5-MeO-AMT (α,O-dimethylserotonin)—demonstrate activity and elicit significant centrally mediated effects in human subjects. These compounds function as non-selective serotonin receptor agonists, similar to serotonin itself, and are classified as serotonergic psychedelics owing to their activation of the serotonin 5-HT_2A receptor. While α-methylserotonin has undergone extensive investigation in preclinical research, its evaluation in human subjects remains undocumented.

References

• Mass Spectrometry Spectrum of 5-Hydroxytryptamine.
• Serotonin-Protein Binding Data within the Protein Data Bank (PDB).
• PsychoTropicalResearch: Comprehensive Reviews on Serotonergic Drugs and Serotonin Syndrome.
• University of Bristol's "Molecule of the Month" Feature: Serotonin.
• Scientific American: "60-Second Psych: No Fair! My Serotonin Level Is Low" (Archived 9 December 2023).
• Serotonin Test Interpretation via ClinLab Navigator (Archived 1 February 2010).